BioRestorative Therapies Receives License From New York State Department Of Health To Act As Tissue Bank For Mesenchymal Stem Cell Processing
Portfolio Pulse from Benzinga Newsdesk
BioRestorative Therapies has received a license from the New York State Department of Health to act as a tissue bank for mesenchymal stem cell processing.
May 31, 2023 | 11:07 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioRestorative Therapies has been granted a license to act as a tissue bank for mesenchymal stem cell processing by the New York State Department of Health.
The license from the New York State Department of Health allows BioRestorative Therapies to act as a tissue bank for mesenchymal stem cell processing. This is a positive development for the company as it expands its operations and capabilities in the stem cell industry. The news is directly related to BRTX and is likely to have a positive impact on its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100